SCHEMBL16540160

SCHEMBL16540160

COc1ccc(Cn2nc(OC3CCN(C(=O)OC(C)(C)C)CC3)c3cc(Br)cnc32)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE4A P27815 2/20 0.42
▸ PDE4B Q07343 2/20 0.42
▸ PDE4C Q08493 2/20 0.42
▸ PDE4D Q08499 2/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ TP53 P04637 2/20 0.42
▸ PDE1B Q01064 1/20 0.42
▸ GPR119 Q8TDV5 3/20 0.41
▸ HTT P42858 1/20 0.41
▸ CACNB4 O00305 2/20 0.41
▸ CACNA1A O00555 2/20 0.41
▸ CACNA1G O43497 2/20 0.41
▸ CACNG3 O60359 2/20 0.41
▸ CACNA1F O60840 2/20 0.41
▸ CACNA1H O95180 2/20 0.41
▸ CACNB3 P54284 2/20 0.41
▸ CACNA2D1 P54289 2/20 0.41
▸ CACNG7 P62955 2/20 0.41
▸ CACNA1B Q00975 2/20 0.41
▸ CACNA1D Q01668 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16535998 0.89 PDE1B (0.44) PDE1B
SCHEMBL27193571 0.81 PDE1B (0.46) PDE1B
SCHEMBL27193455 0.79 PDE1B (0.47) ALDH1A1PDE1B
SCHEMBL16537115 0.79 KIT (0.42) CACNA1H
SCHEMBL1592906 0.76 PDE1B (0.55) ALDH1A1PDE1B
SCHEMBL12234532 0.76 TP53 (0.48) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL16759365 0.74 NPBWR1 (0.49) GPR119CACNB4CACNA1ACACNA1GCACNG3
SCHEMBL1944319 0.74 GPR119 (0.41) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL1592961 0.74 PDE1B (0.53) ALDH1A1PDE1B
SCHEMBL3716849 0.73 MAPT (0.43) ALDH1A1TP53GPR119HTTKDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9725465-B2 Biaryl acetamide compounds and methods of use thereof AMBIT BIOSCIENCES CORPORATION (US) 2017-08-08 — — US disclosed
EP-3039021-A1 BIARYL ACETAMIDE COMPOUNDS AND METHODS OF USE THEREOF Ambit Biosciences Corporation (US) 2016-07-06 — — EP disclosed
WO-2015031613-A1 BIARYL ACETAMIDE COMPOUNDS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORPORATION (US) 2015-03-05 — — WO disclosed
Send feedback